Neurocrine Biosciences

parachute chutes
Biotech

Eric Topol boards Flagship as advisor—Chutes & Ladders

Eric Topol boards Flagship as advisor. Idorsia CEO hits the exit. Mestag adds $40 million, two new C-suiters.
Lifeline

Midsize biotechs form coalition to fight against MFN policy

Feb 25, 2026 1:05pm
colorful brain art model

Neurocrine-Takeda psychiatry pact suffers another phase 2 fail

Nov 11, 2025 6:25am
reshuffle pipeline target reorganize shift change

Neurocrine pens $880M pact with TransThera for immunology target

Nov 3, 2025 5:42am
Alps parachute rainbow mountains

Sanofi vaccine vet vaults to GSK—Chutes & Ladders

Jun 13, 2025 8:30am
ship offload depart tugboat boat

Neurocrine hands back 2 CNS gene therapy programs to Voyager

May 7, 2025 7:30am